Abstract: A driver arrangement for a lighting unit. The drive arrangement comprises an independent first driver mainly for driving a first output capacitor and an independent second driver configured to mainly driving the second output capacitor. The driver arrangement is configured to allow an independent first driver to charge the second output capacitor when one or more predetermined criteria are met.

Abstract: A non-invasive time domain reflection probe calibration method includes: using different volume ratio of ethanol and deionized water mixed solution to calculate a test target's medium weight coefficient and waveguide length of the non-invasive time domain reflection probes; using different concentrations of NaCl solutions to calibrate a waveguide geometric dimensioning of the non-invasive time domain reflection probes; preparing compacted soil samples with known different moisture contents and densities, and calibrating a correlation parameter of compacted soil samples' dielectric constant and conductivity with moisture content and density. The method not only determines the sensitivity of the test target medium of the non-invasive time domain reflection probes, but also obtains the waveguide length and geometric dimensioning of the probe, and realizes an accurate test of moisture content and density of the soil.

Abstract: The present invention relates to the technical field of medicines, and relates to a polyethylene glycol conjugated drug, a preparation method therefor and the use thereof. In particular, the present invention relates to a polyethylene glycol conjugated drug as shown in formula I or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, and the use thereof in the preparation of a drug.

Abstract: The present invention relates to a polyethylene glycol conjugate medicament, a preparation method therefor and use thereof, and in particular relates to a polyethylene glycol conjugate medicament represented by formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and an intermediate of the same, a pharmaceutical composition comprising the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and use thereof in preparing a medicament.

Abstract: The present application relates to a pyrazole boronic acid compound represented by the following formula I, pharmaceutically acceptable salts or stereoisomers thereof, a pharmaceutical composition containing same, and uses thereof. The compound, the pharmaceutically acceptable salts or stereoisomers thereof and the pharmaceutical composition containing same can be used for preparing proteasome inhibitors.

Abstract: Provided by the present invention is a loop, comprising a fixing plate and a suture, wherein the fixing plate is provided with at least two threading holes, the suture is wound to form a first coil and a second coil, the first coil and the second coil are arranged on a same side of the fixing plate, and two ends of each of the first coil and the second coil are configured to pass through the threading holes; the two ends of the first coil are movably connected to form a first adjustable portion, a third end of the second coil is continuously connected to a first end of the first coil to form a fixing portion, the fixing portion is configured to compress a fourth end of the second coil to form a second adjustable portion.

Abstract: Provided by the present invention is a loop, comprising a fixing plate and at least one suture, wherein the suture is wound to form a first coil and a second coil and is provided on a first side of the fixing plate, a first end of the first coil and a third end of the second coil pass through different threading holes and are connected on a second side of the fixing plate to form a first fixing portion, so that the length of the first coil and the length of the second coil can be adjusted through the first fixing portion under the action of a graft.

Abstract: This application discloses a photographing method and an apparatus in, relates to the photographing field and the field of image processing technologies. When a plurality of persons take a group photo, no help from a third party is required. Therefore, implementation is convenient, and user satisfaction with a group photo result can be improved, thereby improving user experience. The method includes: obtaining a first image including an image of a first photographing background and the first to-be-photographed subject; then displaying a first preview interface, the first preview image includes an image of a second photographing background and an image of the second to-be-photographed subject, and a degree of coincidence between the image of the second photographing background and the image of the first photographing background is greater than or equal to a preset degree of coincidence; obtaining a target image based on the first image and the first preview image.

Abstract: Provided by the present invention is a medical loop, comprising a fixing plate and at least one suture, wherein the fixing plate is provided with at least two threading holes, and the first suture is wound to form a first coil; two ends of the first coil both pass through the threading holes, and the first coil is connected to the fixing plate to form a first fixing portion and a second fixing portion for fixing a graft, so that the first coil can automatically adjust the lengths of the first fixing portion and the second fixing portion under the action of the graft; two ends of the first coil are respectively a first telescopic end and a first fixed end, the first telescopic end and the first fixed end are movably connected to form a first elastic portion, so that the length of the first coil can be adjusted through the first elastic portion under the action of artificial external force, and the first coil cannot be lengthened and retreated due to the pulling force of the graft when no artificial external fo

Abstract: The present invention relates to the technical field of medicines, and relates to a polyethylene glycol conjugated drug, a preparation method therefor and the use thereof. In particular, the present invention relates to a polyethylene glycol conjugated drug as shown in formula I or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, and the use thereof in the preparation of a drug.

Abstract: The present invention relates to a polyethylene glycol conjugate medicament, a preparation method therefor and use thereof, and in particular relates to a polyethylene glycol conjugate medicament represented by formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and an intermediate of the same, a pharmaceutical composition comprising the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and use thereof in preparing a medicament.

Abstract: The disclosure relates to the technical field of medicine, specifically to a polyethylene glycol conjugated drug, a preparation method therefor and use thereof, and relates in particular to a polyethylene glycol conjugated drug represented by formula (I) or a pharmaceutically acceptable salt thereof. The disclosure further relates to a method for preparation of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, and use of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof in preparation of a medicament.

Abstract: The disclosure relates to the technical field of medicine and in particular to a polyethylene glycol conjugated drug of formula I or a pharmaceutically acceptable salt thereof. The disclosure further relates to a method for preparation and an intermediate of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, and use of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof in preparation of a medicament.